Compounds > 1-naphthylamine
Page last updated: 2024-08-18

1-naphthylamine and Basal Ganglia Diseases

1-naphthylamine has been researched along with Basal Ganglia Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rapport, D; Shihabuddin, L1
de Burlet, HM; Jansen Steur, EN; Kölling, P1
Byerly, MJ; Christensen, RC1

Other Studies

3 other study(ies) available for 1-naphthylamine and Basal Ganglia Diseases

ArticleYear
Sertraline and extrapyramidal side effects.
    The American journal of psychiatry, 1994, Volume: 151, Issue:2

    Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Depressive Disorder; Dystonia; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
[Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant].
    Nederlands tijdschrift voor geneeskunde, 1996, Jul-13, Volume: 140, Issue:28

    Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Mandibular dystonia associated with the combination of sertraline and metoclopramide.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:12

    Topics: 1-Naphthylamine; Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Dystonia; Female; Gastroesophageal Reflux; Humans; Mandible; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Sertraline

1996